ENTPD6
Basic information
Region (hg38): 20:25195693-25228075
Previous symbols: [ "CD39L2", "IL6ST2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ENTPD6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 23 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 3 | 1 |
Variants in ENTPD6
This is a list of pathogenic ClinVar variants found in the ENTPD6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-25206583-T-C | not specified | Uncertain significance (Dec 19, 2022) | ||
20-25207087-C-A | not specified | Uncertain significance (Dec 27, 2023) | ||
20-25207179-T-C | not specified | Uncertain significance (May 24, 2023) | ||
20-25207184-A-G | not specified | Uncertain significance (Jul 20, 2021) | ||
20-25207220-G-A | not specified | Uncertain significance (Apr 28, 2022) | ||
20-25207251-C-G | not specified | Uncertain significance (Mar 25, 2024) | ||
20-25207262-G-C | not specified | Uncertain significance (Oct 17, 2023) | ||
20-25207328-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
20-25207368-A-C | not specified | Uncertain significance (May 23, 2023) | ||
20-25209858-C-T | not specified | Uncertain significance (Mar 29, 2022) | ||
20-25213366-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
20-25214913-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
20-25216654-T-G | not specified | Uncertain significance (Dec 17, 2023) | ||
20-25216716-G-A | not specified | Likely benign (Dec 07, 2023) | ||
20-25216721-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
20-25216728-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
20-25216729-G-A | not specified | Uncertain significance (Dec 12, 2022) | ||
20-25217545-G-A | not specified | Likely benign (Apr 12, 2022) | ||
20-25218563-G-A | not specified | Uncertain significance (Nov 13, 2023) | ||
20-25221235-A-T | not specified | Uncertain significance (Apr 13, 2022) | ||
20-25222852-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
20-25222894-G-A | not specified | Uncertain significance (Apr 19, 2024) | ||
20-25222904-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
20-25222951-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
20-25222961-C-T | not specified | Uncertain significance (Jun 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ENTPD6 | protein_coding | protein_coding | ENST00000376652 | 14 | 31037 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000118 | 0.988 | 125693 | 0 | 55 | 125748 | 0.000219 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.766 | 261 | 298 | 0.875 | 0.0000185 | 3110 |
Missense in Polyphen | 85 | 109.86 | 0.77373 | 1202 | ||
Synonymous | 0.747 | 118 | 129 | 0.916 | 0.00000901 | 976 |
Loss of Function | 2.29 | 14 | 26.8 | 0.522 | 0.00000121 | 318 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000549 | 0.000541 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000220 | 0.000217 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000195 | 0.000193 |
Middle Eastern | 0.000220 | 0.000217 |
South Asian | 0.000359 | 0.000327 |
Other | 0.000335 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Might support glycosylation reactions in the Golgi apparatus and, when released from cells, might catalyze the hydrolysis of extracellular nucleotides. Hydrolyzes preferentially nucleoside 5'-diphosphates, nucleoside 5'-triphosphates are hydrolyzed only to a minor extent, there is no hydrolysis of nucleoside 5'-monophosphates. The order of activity with different substrates is GDP > IDP >> UDP = CDP >> ADP (By similarity). {ECO:0000250}.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Nucleobase catabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NTPDase proteins;Purine metabolism;Metabolism;Pyrimidine metabolism;Purine nucleotides nucleosides metabolism;Pyrimidine nucleotides nucleosides metabolism
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.848
- rvis_EVS
- 0.94
- rvis_percentile_EVS
- 89.86
Haploinsufficiency Scores
- pHI
- 0.176
- hipred
- N
- hipred_score
- 0.250
- ghis
- 0.456
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.608
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Entpd6
- Phenotype
- homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- response to magnesium ion;nucleobase-containing small molecule catabolic process;response to calcium ion
- Cellular component
- Golgi membrane;extracellular region;extracellular space;Golgi apparatus;plasma membrane;cell surface;integral component of membrane
- Molecular function
- guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity;nucleoside-diphosphatase activity;nucleoside-triphosphatase activity;uridine-diphosphatase activity